Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Surmodics, Inc. (NASDAQ: SRDX) stands at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $516 million, this Eden Prairie,..
Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing investor attention with its innovative focus on central nervous system (CNS) disorders and a striking potential upside of 129.07%. As a clinical-stage biopharmaceutical..
For investors seeking opportunities in the biotechnology sector, Precigen, Inc. (NASDAQ: PGEN) offers a compelling proposition with a potential upside of 126.65%, according to analyst ratings. As a discovery and..
PureTech Health plc (NASDAQ: PRTC) is making waves in the biotechnology sector, presenting an intriguing opportunity for investors looking to capitalize on significant growth potential. With a market capitalization of..
Investors are increasingly turning their attention to MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company that is pioneering innovative treatments in the healthcare sector. With a remarkable potential upside..
Verastem, Inc. (NASDAQ: VSTM), a U.S.-based biopharmaceutical company, is catching the eye of investors with its impressive potential upside of 75.26%, according to recent analyst ratings. As a development-stage company..
OrthoPediatrics Corp. (NASDAQ: KIDS) is positioning itself as a key player in the pediatric orthopedics market, offering specialized medical devices designed specifically for children. With a current market capitalization of..
Cogent Biosciences, Inc. (NASDAQ: COGT) is currently capturing the attention of investors with its promising potential upside and strategic focus on precision therapies for genetically defined diseases. Headquartered in Waltham,..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a commercial-stage biotechnology company, is gaining investor attention with a notable potential upside of 144.18%. Specializing in the development of treatments for rare diseases through..
Abivax SA (ABVX), a French biotechnology company, is capturing attention in the investment community with its promising potential upside of 27.8%, as indicated by analyst ratings. Specializing in developing therapeutics..
AngioDynamics, Inc. (NASDAQ: ANGO), a significant player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors with a potential upside of 101.21%. With..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company headquartered in Gaithersburg, Maryland, is making waves in the biotechnology sector. With a focus on developing innovative treatments for obesity, metabolic, and..
For investors with a keen eye on the healthcare sector, Embecta Corp. (NASDAQ: EMBC) presents a compelling opportunity with its focus on diabetes management solutions. Based in Parsippany, New Jersey,..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands out in the competitive biotechnology landscape with its promising pipeline aimed at addressing cancer resistance mechanisms, a challenging frontier in oncology. With a market..
Investors seeking opportunities in the biotechnology sector may find Tyra Biosciences, Inc. (NASDAQ: TYRA) an intriguing prospect. With its focus on precision medicines targeting fibroblast growth factor receptor (FGFR) biology,..
Investors eyeing the biotechnology sector may find Humacyte, Inc. (NASDAQ: HUMA) an intriguing proposition, especially with a potential upside of 500.65% as indicated by analyst target prices. As of recent..
Akso Health Group (NASDAQ: AHG), a key player in China’s burgeoning healthcare sector, is turning heads with its remarkable 415.8% revenue growth. Despite the lack of traditional valuation metrics like..
Investors looking for opportunities in the biotechnology sector may find Inventiva S.A. – American Depositary Shares (IVA) an intriguing prospect, with a notable potential upside of 155.76%. Headquartered in Daix,..
Upstream Bio, Inc. (NASDAQ: UPB) is making waves in the biotechnology sector, capturing the attention of investors with its promising potential upside of 179.97%. This clinical-stage biotech company, headquartered in..
